Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
283 |
|
| Actual shortage: | 7 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 260 (92%) | |
Discontinuation Reports |
50 |
|
| To be discontinued: | 6 (12%) | |
| Discontinued: | 44 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
4 (31%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-07-16 | 2019-11-05 | 89476 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-11-29 | 2020-01-24 | 100061 |
| AVAPRO | 300MG | TABLET | Resolved | 2020-03-12 | 2020-04-22 | 108533 |
| AVAPRO | 300MG | TABLET | Resolved | 2021-12-02 | 2022-06-09 | 150376 |
| AVAPRO | 300MG | TABLET | Resolved | 2022-08-02 | 2022-09-17 | 165911 |
| PLAVIX | 75MG | TABLET | Resolved | 2018-11-29 | 2019-01-25 | 68065 |
| PLAVIX | 75MG | TABLET | Resolved | 2019-06-19 | 2019-08-12 | 87048 |
| PLAVIX | 75MG | TABLET | Resolved | 2022-07-19 | 2022-09-14 | 165000 |
| PLAVIX | 75MG | TABLET | Resolved | 2022-09-13 | 2023-01-18 | 169210 |
| PLAVIX | 75MG | TABLET | Resolved | 2023-02-10 | 2023-02-15 | 184405 |
| PLAVIX | 75MG | TABLET | Resolved | 2023-06-07 | 2023-09-16 | 193873 |
| PLAVIX | 75MG | TABLET | Resolved | 2023-09-28 | 2023-12-12 | 205398 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
| AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| ZUACTA | 0.075% | CREAM | Discontinued | 2020-07-30 | 2020-07-30 | 121381 |
| FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| CLAFORAN - PWS INJ 1.0G/VIAL | 1G | POWDER FOR SOLUTION | Discontinued | 2017-03-16 | 2017-05-02 | 3103 |
| CLAFORAN - PWS INJ 2.0G/VIAL | 2G | POWDER FOR SOLUTION | Discontinued | 2017-03-20 | 2017-04-05 | 3685 |
| ADLYXINE | 0.05MG 0.1MG | SOLUTION KIT | Discontinued | 2019-02-15 | 2019-02-15 | 75803 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| ATROVENT NASAL SPRAY | 21MCG | SOLUTION | Discontinued | 2018-10-17 | 2018-10-17 | 64493 |
| ATROVENT NASAL SPRAY | 42MCG | SOLUTION | Discontinued | 2018-10-17 | 2020-07-27 | 64496 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |